A Study to Assess the Effects of Fluvoxamine on Savolitinib Exposure in Healthy Male Subjects

Trial Identifier:	D5084C00015
Sponsor:	AstraZeneca
Collaborator:	Parexel
NCTID::	NCT05888207
Start Date:	June 2023
Primary Completion Date:	August 2023
Study Completion Date:	August 2023
Condition:	Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
US, MD	Brooklyn, MD, US, 21225

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.